Telix launches US$550M convertible note refinancing
Telix Pharmaceuticals (ASX:TLX) announced the launch of a US$550 million offering of senior unsecured convertible notes due 2031.

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
Telix Pharmaceuticals (ASX:TLX) announced the launch of a US$550 million offering of senior unsecured convertible notes due 2031.
PainChek (ASX:PCK) announced a master services agreement with Sabra Health Care REIT (NASDAQ:SBRA).
Simble Solutions (ASX:SIS) announced a series of administrative and leadership updates following its latest general meeting.
Black Canyon (ASX:BCA) commenced a pivotal resource definition and expansion drilling programme at its Wandanya Project.
Clarity Pharmaceuticals (ASX:CU6) has announced a landmark commercial manufacturing agreement with Nucleus RadioPharma.
Nexus Minerals (ASX:NXM) starts a major 22,000m drilling programme at the Wallbrook Gold Project to drive resource growth
Tyler Technologies (NYSE:TYL) announced on Tuesday, April 14, 2026, that it has finalized the acquisition of For The Record, a prominent innovator in digital court-recording and legal transcription.
Ligand Pharmaceuticals (NASDAQ:LGND) announced on Tuesday, April 14, 2026, that its partner, Travere Therapeutics, has received full U.S. Food and Drug Administration (FDA) approval for FILSPARI (sparsentan).
Rent the Runway (NASDAQ:RENT) reported strong financial results for the fourth quarter of fiscal year 2025, ended January 31, 2026, as the company significantly narrowed its losses and expanded its subscriber base.
Creative Realities (NASDAQ:CREX), a provider of digital signage and AdTech solutions, reported significant growth for its fiscal fourth quarter ended December 31, 2025.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy